Why the study?
Does an automated chromogenic assay of prothrombin (CPA) satisfactorily monitor doses in patients on long term oral anticoagulant treatment?
Does an automated chromogenic assay of prothrombin (CPA) satisfactorily monitor doses in patients on long term oral anticoagulant treatment?
An automated chromogenic assay of prothrombin provides a satisfactory and potentially safer alternative to conventional tests for monitoring oral anticoagulant therapy.
Answers are grounded in this paper and cite their sources.
Supports feasibility of automated chromogenic assay in small cohort; leaves open need for randomized validation versus conventional monitoring.
Doses of oral anticoagulants in 50 patients on long term treatment were easily and satisfactorily monitored over six months by an automated chromogenic assay of prothrombin (CPA). It is suggested that chromogenic assay of one or more of the vitamin K dependent coagulation factors would provide a readily standardised alternative to those conventional tests which depend on human brain derived reagents, now regarded as a biohazard.
No takes yet. Share an insight, caveat, or question.
O’Donnell et al. (1987) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: